News | Radial Access | March 08, 2016

Merit Medical Announces First European ThinkRadial Education Course

Course is designed to provide training to interventionalists on the transradial approach

Merit Medical, ThinkRadial training course, radial interventional access, first in Europe

March 8, 2016 — Merit Medical Systems Inc. announced that the first ThinkRadial course to be held at its European headquarters in Maastricht, the Netherlands, took place Feb. 25-26. The ThinkRadial program serves to educate and train interventional cardiologists, interventional radiologists and vascular surgeons around the world about using the radial artery, as an alternative to the femoral artery, to gain access for interventional procedures.

The two-day ThinkRadial course, which began in the United States in 2014, provides a full spectrum of didactic and hands-on educational opportunities. This course marks the first in a series of two-day course offerings slated for 2016 at Merit’s European HQ, in addition to ThinkRadial courses in the U.S. and workshops and symposia throughout the year around the world.

The course will feature two concurrent tracks for interventional cardiologists and interventional radiologists, and will be held in Merit’s new training center that features hands-on training modules, including flow models for radial and femoral catheterization and pulsatile puncture arms. The Interventional Cardiology track will be proctored by Tom Kiernan, M.D., of Limerick Hospital, Limerick, Ireland; and the Interventional Radiology track will be led by Darren Klass, M.D., of Vancouver General Hospital & UBC Hospital in Vancouver, British Columbia, Canada. In addition to the course proctors, Ferdinand Kiemeneij, M.D., regarded as the “father of transradial intervention,” will speak as a special guest of honor about his experience with radial access and his vision for the future of the technique.

“I am honored to join the esteemed faculty at this European training event to discuss the benefits of transradial approach for interventional procedures,” said Kiemeneij. “Transradial intervention is rapidly gaining acceptance globally, and I believe that training and education are paramount to increasing adoption and bringing this option to patients worldwide. I look forward to participating in this course and educating attendees on the latest science and research about the radial approach and my experience in performing this procedure.”

For more information: www.meritmedical.com

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init